[HTML][HTML] Selective granulocyte and monocyte apheresis in inflammatory bowel disease: Its past, present and future
XL Chen, JW Mao, YD Wang - World Journal of Gastrointestinal …, 2020 - ncbi.nlm.nih.gov
The etiology and pathogenesis of inflammatory bowel disease (IBD), including ulcerative
colitis and Crohn's disease, are not fully understood so far. Therefore, IBD still remains …
colitis and Crohn's disease, are not fully understood so far. Therefore, IBD still remains …
Rheumatoid arthritis: development after the emergence of a chemokine for neutrophils in the synovium
H Katayama - BioEssays, 2021 - Wiley Online Library
Rheumatoid arthritis (RA) may not be a multifactorial disease; it can be hypothesized that RA
is developed through a series of events following a triggering event, which is the emergence …
is developed through a series of events following a triggering event, which is the emergence …
Quantification of joint space width difference on radiography via phase-only correlation (POC) analysis: A phantom study comparing with various tomographical …
A Taguchi, S Shishido, Y Ou, M Ikebe, T Zeng… - Journal of Digital …, 2021 - Springer
Several visual scoring methods are currently used to assess progression of rheumatoid
arthritis (RA) on radiography. However, they are limited by its subjectivity and insufficient …
arthritis (RA) on radiography. However, they are limited by its subjectivity and insufficient …
[HTML][HTML] Leukocytapheresis for rheumatoid arthritis cases that are super-resistant to any class of biological drugs and tofacitinib
S Mori - Transfusion and Apheresis Science, 2020 - Elsevier
Many biological disease-modifying antirheumatic drugs (bDMARDs) and targeted synthetic
DMARDs (tsDMARDs) are currently available as treatment options for rheumatoid arthritis …
DMARDs (tsDMARDs) are currently available as treatment options for rheumatoid arthritis …
Leukocytapheresis therapy for rheumatoid arthritis: Results compared with control trial
J Huang, Q Wang, M Gao, F Yang, B Mu… - … Therapies in Health …, 2020 - search.proquest.com
Abstract Context• Rheumatoid arthritis (RA) is a chronic multisystem autoimmune disease,
mainly characterized by synovitis and with symmetrical joint involvement. LCAP therapy for …
mainly characterized by synovitis and with symmetrical joint involvement. LCAP therapy for …
[PDF][PDF] Extracorporeal Immunoparmacotherapy in Rheumatoid Arthritis
VA Voinov, YV Voinova - Recent Research in …, 2020 - orthopaedicsjournal.net
Worldwide, about 1% of population or 165 million people suffer from rheumatoid arthritis.
And, despite all the achievements of modern medicine, the mortality rate is 1.6-2.0 times …
And, despite all the achievements of modern medicine, the mortality rate is 1.6-2.0 times …
アフェレシスにおける最近の進歩
花房規男 - 人工臓器, 2020 - jstage.jst.go.jp
アフェレシスにおける最近の進歩 Page 1 ●人工臓器 ─最近の進歩 162 人工臓器49巻3号 2020年
アフェレシスにおける最近の進歩 東京女子医科大学腎臓病総合医療センター血液浄化療法科 花房 …
アフェレシスにおける最近の進歩 東京女子医科大学腎臓病総合医療センター血液浄化療法科 花房 …